|
|
|
European Pharmaceutical Contractor
|
| In recent decades the types of therapy in research and the marketplace have undergone
some radical transformations. Where most therapies were once squarely aimed at
endemic diseases of the West, the recent biotechnology revolution has hugely increased
the number of therapeutic targets, with more complex medicines – often parenteral –
aimed at less common illnesses or at more specific sub groups of patients with more
common conditions. For example, we are seeing oncology therapies targeting smaller
sub groups of patients, the rise of therapies for orphan indications, the targeting of
antibodies and proteins for specific complications of illness such as preventing SLE crisis
and so on. The drive towards community medicine means an infrastructure has grown
up to administer these medicines in the home and to run clinical trials in the same way. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
3rd African Regulatory Conference (ARC)
3-4 May 2012, Accra, Ghana
The African Regulatory Conference offers the opportunity for key stakeholders active on the continent, including representatives from Ministry of Health, local and multinational pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions to Present P.L.E.A.S.E.® Professional for Transdermal Drug Delivery at DDP in Las Vegas
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will be giving a scientific company presentation during the “Drug Delivery Partnerships” conference from 25th -27th January 2012 in Las Vegas, USA.
More info >> |
|
|
